Clinical experience with nonstandard doses ofinterferon alfa-2b and ribavirin in the treatment of chronic hepatitis C infection: A retrospective analysis

BACKGROUND: Hepatitis C virus (HCV) infection is the most common blood-borne virus in the United States. Several mono- and combination therapies have been approved by the US Food and Drug Administration for the treatment of HCV, but their routes of administration, dosing approaches, eras of introduc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hare, C. Bradley, Loveland, Jacqueline J., Chu, Alice, Morris, Jonathan A., Gotz, Vincent, Klaskala, Winslow
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2005
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4003805/
https://ncbi.nlm.nih.gov/pubmed/24790244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.curtheres.2005.10.005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados